SCHEMBL20445486

SCHEMBL20445486

CC(=O)CN(CCN(CC(=O)C(C)C)CC(=O)C(C)C)CC(=O)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.39
EYA2 O00167 1/20 0.39
APP P05067 1/20 0.39
ACE P12821 1/20 0.39
KDM4E B2RXH2 2/20 0.37
ALOX15 P16050 2/20 0.37
LMNA P02545 1/20 0.37
CHRM2 P08172 1/20 0.37
ADRA2A P08913 1/20 0.37
TSHR P16473 1/20 0.37
DRD1 P21728 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
CYP2C19 P33261 1/20 0.37
ADRA1A P35348 1/20 0.37
DRD3 P35462 1/20 0.37
BLM P54132 1/20 0.37
PMP22 Q01453 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20438445 0.91 TDP1 (0.46) TDP1EYA2APPACEKDM4E
SCHEMBL15982284 0.90 TDP1 (0.56) TDP1EYA2APPACEKDM4E
SCHEMBL24403604 0.89 TDP1 (0.34) TDP1EYA2APPACEKDM4E
SCHEMBL19543431 0.88 TDP1 (0.48) TDP1EYA2APPACEKDM4E
SCHEMBL18973014 0.87 EYA2 (0.30) TDP1EYA2APPACE
SCHEMBL22013281 0.85 BLM (0.50) KDM4EBLMPMP22
SCHEMBL3639097 0.83 TDP1 (0.53) TDP1EYA2APPACEKDM4E
SCHEMBL20202259 0.82 TDP1 (0.64) TDP1EYA2APPACEKDM4E
SCHEMBL13863096 0.80 TDP1 (0.65) TDP1EYA2APPACEKDM4E
SCHEMBL13863095 0.80 TDP1 (0.65) TDP1EYA2APPACEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2019-10-08 US disclosed
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2018-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, MRPS18A TDP1 4156/4885EYA2 4379/4885APP 2560/4885
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF MRPL38, CXCL8, ALG8 TDP1 3504/4885EYA2 4637/4885APP 2885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.